Listen to the Latest ‘KFF Health News Minute’ – KFF Health News
“Health Minute” brings original health care and health policy reporting from the KFF Health News newsroom to the airwaves each week.
“Health Minute” brings original health care and health policy reporting from the KFF Health News newsroom to the airwaves each week.
Zach Klaassen discusses the ARAMON trial with Andrew Laccetti, which focuses on the impact of enzalutamide and darolutamide on testosterone levels in patients with high-risk…
APCCC 2024, Advanced Prostate Cancer, How to Select Patients for Adjuvant Therapy After Radical Prostatectomy, pT3bN, RADICALS-RT trial, Adjuvant external beam radiotherapy, androgen deprivation therapy…
This e-book provides information about the advantages and disadvantages of different activity tracking solutions in research use. The guide is not a systematic review but…
Sam Chang and Roger Li delve into a study examining genetic profiles in non-muscle invasive bladder cancer and adjacent benign bladder tissue. Conducted on a…
Program: Beyond Androgen Blockade – New Pathways and Novel Treatments in mHSPC and mCRPC Part of an Independent Medical Education Initiative Supported by LOXO@Lilly Biographies:…
California state lawmakers this year are continuing their progressive tilt on health policy, debating bills banning an ingredient in Froot Loops and offering free condoms…
The authors of a new study argue the heralded arrival of biosimilars failed to fully deliver on their promise.
APCCC 2024 global access of advanced prostate cancer, Prostate cancer incidence, radical prostatectomy, pidemiological differences of prostate cancer between China and the United States.
APCCC 2024 how to identify aggressive variant prostate cancer, Castrate-resistant prostate cancer, aggressive variant prostate cancer, neuroendocrine prostate cancer, SPOP alterations.
APCCC 2024 promise and pitfalls of social media and artificial intelligence for prostate cancer, Lancet Commission on Prostate Cancer,